Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
NKTR-255 + CAR-T Therapy for Large B-cell Lymphoma
Recruiting1 awardPhase 1
Seattle, Washington
This trial is testing the combination of NKTR-255 and CAR-T cell therapy to treat patients with large B-cell lymphoma that has relapsed or is refractory.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.